insights_auto
Why is GNMSF up 11.82%?
Dive Deeperchevron_right
GNMSF:OTCMKTS
Genmab A/S
$396.97
arrow_upward
+11.82%(+41.97) 1D
Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNMSF...
Open
$355.00
High
$396.97
Low
$351.17
Mkt. cap
23.46B
Avg. vol.
84.00
Volume
1.66K
52-wk high
$396.97
52-wk low
$232.50
Beta
0.73
Shares outstanding
62.41M
No. of employees
3K
Open
$355.00
High
$396.97
Low
$351.17
Mkt. cap
23.46B
Avg. vol.
84.00
Volume
1.66K
52-wk high
$396.97
52-wk low
$232.50
Beta
0.73
Shares outstanding
62.41M
No. of employees
3K
News stories
From web sources and news partners
AD HOC NEWS
·
6 hours ago
Genmab stock gains 5.32 percent on Rina-S data
TipRanks
·
6 hours ago
Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL
Investing.com
·
6 hours ago
Why is Genmab stock surging today?
TradingKey
·
6 hours ago
Genmab A/S Stock (GMAB) Moved Up by 13.01% on Oct 5: Key Drivers Unveiled
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
FoundedJun 11, 1998
Headquarters-
SectorBiotechnology
Websitegenmab.com